Access to drugs for TB webinar

Despite the development of new drugs, and trials to support more effective treatment regimens for TB, cure cannot be achieved without access to medicines. Drug pricing, access policies and patent issues are often responsible for inequalities in getting access to lifesaving medicines to people that need most. This webinar aims to describe those issues, identify the parts of the process most relevant to resolve, and the specific problems with individual drugs.  Two talks from experts in the field will be followed by discussions with panel members from different institutions across the world. The event will be recorded. Speaker information will appear here.